CVE-2024-44187: A cross-origin issue existed with "iframe" elements
Source GCVE Database
Not known to be exploited · CVSS 6.5 Medium.
Data as of 4 Nov 2026, 17:21 UTC
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 16 Sep 2024
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 4 Nov 2026.
What to do
AI-suggested
This issue is fixed in Safari 18, visionOS 2, watchOS 11, macOS Sequoia 15, iOS 18, iPadOS 18, and tvOS 18. Users and administrators should update to these versions to remediate the vulnerability. No additional mitigation steps are indicated by the vendor advisory.
Description
CVE-2024-44187 is a cross-origin security issue involving iframe elements in Apple operating systems. The flaw allowed a malicious website to potentially exfiltrate data across origins due to insufficient tracking of security origins. This vulnerability has been fixed in Safari 18, visionOS 2, watchOS 11, macOS Sequoia 15, iOS 18, iPadOS 18, and tvOS 18.
References
- nvd.nist.gov/vuln/detail/CVE-2024-44187 (opens in a new tab)
- lists.debian.org/debian-lts-announce/2024/11/msg00019.html (opens in a new tab)
- support.apple.com/en-us/121238 (opens in a new tab)
- support.apple.com/en-us/121240 (opens in a new tab)
- support.apple.com/en-us/121241 (opens in a new tab)
- support.apple.com/en-us/121248 (opens in a new tab)
- support.apple.com/en-us/121249 (opens in a new tab)
- support.apple.com/en-us/121250 (opens in a new tab)
- seclists.org/fulldisclosure/2024/Sep/32 (opens in a new tab)
- seclists.org/fulldisclosure/2024/Sep/33 (opens in a new tab)
- seclists.org/fulldisclosure/2024/Sep/36 (opens in a new tab)
- seclists.org/fulldisclosure/2024/Sep/37 (opens in a new tab)